Christian Hendershot, PhD

Professor of Population and Public Health Sciences, Psychology, and Psychiatry and the Behavioral Sciences

Image of Christian Hendershot, PhD
Is this your profile? Click to edit

Overview

Dr. Hendershot is a Professor of Population and Public Health Sciences and Director of Clinical Research, USC Institute for Addiction Science. He is also a member of the USC Norris Comprehensive Cancer Center. He completed his Ph.D. in clinical psychology at the University of Washington, followed by postdoctoral training at the University of New Mexico. Prior to joining USC Dr. Hendershot held faculty positions at the University of North Carolina at Chapel Hill and the Centre for Addiction and Mental Health/University of Toronto, where he held a Canada Research Chair in Alcohol Use Disorders. Dr. Hendershot’s research utilizes clinical, cognitive, neuroscience and psychopharmacology methods to study risk factors and candidate treatments for substance use disorder. His current projects include clinical trials to investigate the efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists as novel treatments for alcohol use disorder and tobacco use disorder.

Awards

  • Government of Canada: Canada Research Chair, 2016
     – 2021
  • Canadian Institutes of Health Research: The Peter Lougheed New Investigator Award, 2013

Education and Training

  • University of Washington, Seattle, WA — Ph.D. — 2009 — Clinical Psychology
  • University of New Mexico, Albuquerque, NM — Postdoctoral Fellowship — 2010

Publications

  • Identifying Behavior Change Techniques for Digital Interventions Addressing Alcohol and Tobacco Co-Use: Findings From a Delphi Consensus Study. JMIR Form Res. 2026 Jul 03; 10:e88996.. View in PubMed
  • The Effects of Personalized Feedback About ALDH2*2, Alcohol Use, and Associated Health Risks on Drinking Intention and Consumption: The Role of Self-Efficacy and Perceived Threat. Alcohol Clin Exp Res (Hoboken). 2026 Jun; 50(6):e70291.. View in PubMed
  • Predictive and discriminant validity of the Impaired Control Scale – Cannabis (ICS-C): an intensive longitudinal study of daily cannabis use outcomes. J Cannabis Res. 2026 May 09; 8(1).. View in PubMed
  • GLP-1 therapies: an emerging approach for alcohol reduction? Lancet. 2026 May 02; 407(10540):1658-1659. Hendershot CS , Klein KR . View in PubMed
  • Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial. JAMA Netw Open. 2026 May 01; 9(5):e2614898.. View in PubMed
  • Therapeutic Potential of Glucagon-Like Peptide-1 Receptor Agonists for Smoking Cessation. Biol Psychiatry. 2026 Apr 10.. View in PubMed
  • Correction: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development. Transl Psychiatry. 2026 Mar 16; 16(1).. View in PubMed
  • Lipopolysaccharide and imiquimod stimulation of potential immune biomarkers in whole blood predict alcohol use disorder risk based on AUDIT scores. Alcohol Clin Exp Res (Hoboken). 2026 Feb; 50(2):e70236.. View in PubMed
  • Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development. Transl Psychiatry. 2026 Jan 29; 16(1):55.. View in PubMed
  • Smoke, sip, sleep, repeat: Investigating daily-level bidirectional relationships of separate and simultaneous use of alcohol and cannabis with sleep. Psychol Addict Behav. 2026 Jan 26.. View in PubMed
  • Effect of dietary stimulation on acute changes in GLP-1, alcohol responses, craving, and attentional bias: a randomized, placebo-controlled laboratory study. Psychopharmacology (Berl). 2025 Dec 09.. View in PubMed
  • Examining eating disorder symptoms and sex as moderators of the association between the sensory attributes and appeal of e-cigarettes. J Psychiatr Res. 2026 Feb; 193:132-139.. View in PubMed
  • Understanding the Relationships between ADHD Symptoms and Cannabis-Related Consequences among Young Adults. Cannabis. 2025; 8(3):116-132.. View in PubMed
  • Alcohol use disorders. Lancet. 2025 Nov 08; 406(10516):2269-2281.. View in PubMed
  • Behaviour change techniques reported in intervention studies of alcohol and tobacco use: a rapid review. Health Psychol Behav Med. 2025; 13(1):2554182.. View in PubMed
  • Internalizing symptoms are indirectly associated with simultaneous alcohol and cannabis use through specific motives for simultaneous use: A longitudinal study of young adults. Alcohol Clin Exp Res (Hoboken). 2025 Oct; 49(10):2319-2333.. View in PubMed
  • Identification of Interleukin-1β in Whole Blood as a Candidate Biomarker for Alcohol Use Disorder Risk Based on AUDIT Scores. Addict Biol. 2025 09; 30(9):e70088.. View in PubMed
  • “It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management. Addict Sci Clin Pract. 2025 08 13; 20(1):68.. View in PubMed
  • Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats. Psychopharmacology (Berl). 2026 May; 243(5):1185-1197.. View in PubMed
  • A longitudinal person-centered analysis of anxiety sensitivity risk for young adult alcohol misuse: Examining the role of injunctive norms. Alcohol Clin Exp Res (Hoboken). 2025 Sep; 49(9):2025-2037.. View in PubMed
  • Cannabis Use Characteristics and Reasons for Product Choices Among Patients Accessing Treatment for Substance Use Disorders: A Mixed-Methods Study. Cannabis. 2025; 8(2):67-84.. View in PubMed
  • An ecological momentary assessment study of predictors for alcohol outcomes in transgender and gender diverse youth. Alcohol Clin Exp Res (Hoboken). 2025 Jul; 49(7):1542-1553.. View in PubMed
  • Associations Between Cannabis Use and Mental Health in Patients Accessing Treatment for Substance Use Disorders: An Exploratory Cross-Sectional Study. Subst Use Misuse. 2025; 60(12):1883-1891.. View in PubMed
  • The Potential Utility of GLP-1 Receptor Agonist Medications for Addiction Treatment: A Narrative Review of Clinical and Epidemiological Evidence. Curr Addict Rep. 2025; 12.. View in PubMed
  • Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine. J Addict Med. 2025 Nov-Dec 01; 19(6):708-715.. View in PubMed
  • Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Apr 01; 82(4):395-405.. View in PubMed
  • Subjective responses to simultaneous alcohol and cannabis use relative to alcohol-only use and cannabis-only use: An ecological momentary assessment investigation. Alcohol Clin Exp Res (Hoboken). 2025 Apr; 49(4):923-940.. View in PubMed
  • Descriptive norms for simultaneous cannabis and alcohol use predict simultaneous use patterns assessed via daily surveys. Psychol Addict Behav. 2025 May; 39(3):254-266.. View in PubMed
  • WITHDRAWN-Administrative Duplicate Publication: Substance Use and Concurrent Disorders: Current Context and the Need for Treatment Integration. Can J Psychiatry. 2025 01 06; 7067437241307902.. View in PubMed
  • Substance Use and Concurrent Disorders: Current Context and the Need for Treatment Integration. Can J Psychiatry. 2025 01; 70(1):5-8.. View in PubMed
  • Utilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease. Liver Transpl. 2025 Jun 01; 31(6):762-769.. View in PubMed
  • Proximal antecedents and acute outcomes of simultaneous alcohol and cannabis use: Systematic review of daily- and event-level studies. Alcohol Clin Exp Res (Hoboken). 2025 Jan; 49(1):43-61.. View in PubMed
  • Within-person and between-person associations of access to environmental reward with alcohol and cannabis use and consequences among young adults. Drug Alcohol Depend. 2024 Oct 01; 263:112417.. View in PubMed
  • Acute analgesic effect of nicotine vaping using three experimental pain induction tasks: a randomized, placebo-controlled laboratory study. Psychopharmacology (Berl). 2025 Feb; 242(2):235-245.. View in PubMed
  • Psychological processes and alcohol reduction in patients with chronic hepatitis C: Results from the HepART trial. Alcohol Clin Exp Res (Hoboken). 2024 Aug; 48(8):1541-1551.. View in PubMed
  • Examining the relationship between public stigma, models of addiction, and addictive disorders. Addict Res Theory. 2025; 33(2):143-149.. View in PubMed
  • Prospective associations of behavioral economic demand for cannabis and alcohol with simultaneous cannabis and alcohol use among young adults. Exp Clin Psychopharmacol. 2024 Oct; 32(5):529-541.. View in PubMed
  • Daily and Momentary Associations Between Gender Minority Stress and Resilience With Alcohol Outcomes. Ann Behav Med. 2024 05 23; 58(6):401-411.. View in PubMed
  • Interactive effects of alcohol and cannabis quantities in the prediction of same-day negative consequences among young adults. Alcohol Clin Exp Res (Hoboken). 2024 May; 48(5):967-979.. View in PubMed
  • Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada – A Qualitative Study. Pharmacopsychiatry. 2024 May; 57(3):141-151.. View in PubMed
  • Effects of Nicotine Content and Preferred Flavor on Subjective Responses to E-cigarettes: A Randomized, Placebo-controlled Laboratory Study. Nicotine Tob Res. 2024 02 22; 26(3):307-315.. View in PubMed
  • How Much THC Is in That Joint? A Daily Diary Study of Young Adults’ Knowledge of the Cannabinoid Content of Cannabis Products. J Stud Alcohol Drugs. 2024 Jul; 85(4):487-496.. View in PubMed
  • GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders. Nat Med. 2023 12; 29(12):2993-2995.. View in PubMed
  • Social Media as Pharmacovigilance: The Potential for Patient Reports to Inform Clinical Research on Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists for Substance Use Disorders. J Stud Alcohol Drugs. 2024 01; 85(1):5-11.. View in PubMed
  • Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study. Int J Behav Med. 2025 Apr; 32(2):276-287.. View in PubMed
  • Executive functions and behavioral economic demand for cannabis among young adults: Indirect associations with cannabis consumption and cannabis use disorder. Exp Clin Psychopharmacol. 2024 Jun; 32(3):305-315.. View in PubMed
  • Screening for cannabis use disorder among young adults: Sensitivity, specificity, and item-level performance of the Cannabis Use Disorders Identification Test – Revised. Addict Behav. 2024 01; 148:107859.. View in PubMed
  • Meta-analysis of acute alcohol effects on response inhibition. Neurosci Biobehav Rev. 2023 09; 152:105274.. View in PubMed
  • Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies. Psychopharmacology (Berl). 2023 Jul; 240(7):1393-1415.. View in PubMed
  • Daily associations between cannabis use and alcohol use among people who use cannabis for both medicinal and nonmedicinal reasons: Substitution or complementarity? Psychol Addict Behav. 2023 Dec; 37(8 . View in PubMed
  • Explanatory pathways linking anxiety sensitivity and alcohol (mis)use: A prospective state-trait analysis among emerging adults. Psychol Addict Behav. 2023 Jun; 37(4):592-605.. View in PubMed
  • Association Between Fatty Acid Amide Hydrolase and Alcohol Response Phenotypes: A Positron Emission Tomography Imaging Study With [11C]CURB in Heavy-Drinking Youth. Biol Psychiatry. 2023 09 01; 94(5):405-415.. View in PubMed
  • Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study. AIDS Behav. 2023 Apr; 27(4):1350-1363.. View in PubMed
  • Effects of varenicline and bupropion on laboratory smoking outcomes: Meta-analysis of randomized, placebo-controlled human laboratory studies. Addict Biol. 2022 09; 27(5):e13218.. View in PubMed
  • Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders. Curr Top Behav Neurosci. 2022; 59:169-191.. View in PubMed
  • Randomized controlled trial of online interventions for co-occurring depression and hazardous alcohol consumption: Primary outcome results. Internet Interv. 2021 Dec; 26:100477.. View in PubMed
  • Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study. Neuropsychopharmacology. 2021 11; 46(12):2112-2120.. View in PubMed
  • Machine learning prediction of blood alcohol concentration: a digital signature of smart-breathalyzer behavior. NPJ Digit Med. 2021 Apr 20; 4(1):74.. View in PubMed
  • Association of the Fatty Acid Amide Hydrolase C385A Polymorphism With Alcohol Use Severity and Coping Motives in Heavy-Drinking Youth. Alcohol Clin Exp Res. 2021 03; 45(3):507-517.. View in PubMed
  • Implications of addiction diagnosis and addiction beliefs for public stigma: A cross-national experimental study. Drug Alcohol Rev. 2021 07; 40(5):842-846.. View in PubMed
  • Correction to: Self-Directed Gambling Changes: Trajectory of Problem Gambling Severity in Absence of Treatment. J Gambl Stud. 2020 Dec; 36(4):1409.. View in PubMed
  • Depression, Environmental Reward, Coping Motives and Alcohol Consumption During the COVID-19 Pandemic. Front Psychiatry. 2020; 11:574676.. View in PubMed
  • Drinking to Cope During COVID-19 Pandemic: The Role of External and Internal Factors in Coping Motive Pathways to Alcohol Use, Solitary Drinking, and Alcohol Problems. Alcohol Clin Exp Res. 2020 10; 44(10):2073-2083.. View in PubMed
  • Characterizing the role of impaired control over alcohol in associations of impulsive personality traits with alcohol use as a function of depressive disorder. Addict Behav. 2021 01; 112:106633.. View in PubMed
  • Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial. Trials. 2020 Jun 29; 21(1):592.. View in PubMed
  • Acute effects of a very low nicotine content cigarette on laboratory smoking lapse: Impacts of nicotine metabolism and nicotine dependence. Addict Biol. 2021 05; 26(3):e12930.. View in PubMed
  • Can the AUDIT consumption items distinguish lower severity from high severity patients seeking treatment for alcohol use disorder? J Subst Abuse Treat. 2020 07; 114:108001. Wardell JD, Cunningham JA, . View in PubMed
  • OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial. Alcohol Clin Exp Res. 2020 04; 44(4):983-991.. View in PubMed
  • Changes in Nicotine Metabolite Ratio Among Daily Smokers Receiving Treatment for Alcohol Use Disorder. Nicotine Tob Res. 2020 02 06; 22(2):256-263.. View in PubMed
  • A review of performance indicators of single-item alcohol screening questions in clinical and population settings. J Subst Abuse Treat. 2020 04; 111:73-85.. View in PubMed
  • Online interventions for problem gamblers with and without co-occurring unhealthy alcohol use: Randomized controlled trial. Internet Interv. 2020 Mar; 19:100307.. View in PubMed
  • Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB. Neuropsychopharmacology. 2020 07; 45(8):1289-1296.. View in PubMed
  • The Prospective Association of Negative Urgency With Hazardous Drinking Via Impaired Control: A Moderating Role of Alcohol Sensitivity. J Stud Alcohol Drugs. 2020 01; 81(1):89-94.. View in PubMed
  • D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction. Neuropsychopharmacology. 2020 04; 45(5):745-752.. View in PubMed
  • A review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease. Am J Transplant. 2019 10; 19(10):2678-2685.. View in PubMed
  • The effect of a clinical decision support system on prompting an intervention for risky alcohol use in a primary care smoking cessation program: a cluster randomized trial. Implement Sci. 2019 08 23; 14(1):85.. View in PubMed
  • An Evaluation of Alcohol Sensitivity in the Context of the Acquired Preparedness Model. Addict Res Theory. 2020; 28(4):335-344.. View in PubMed
  • Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders. Neurosci Biobehav Rev. 2019 10; 105:288-304.. View in PubMed
  • Effects of cannabidiol on alcohol-related outcomes: A review of preclinical and human research. Exp Clin Psychopharmacol. 2019 Aug; 27(4):359-369.. View in PubMed
  • Brief interventions for problem gambling: A meta-analysis. PLoS One. 2019; 14(4):e0214502.. View in PubMed
  • Randomized controlled trial of an Internet intervention for problem gambling provided with or without access to an Internet intervention for co-occurring mental health distress. Internet Interv. 2019 Sep; 17:100239.. View in PubMed
  • The relationship between impaired control, impulsivity, and alcohol self-administration in nondependent drinkers. Exp Clin Psychopharmacol. 2019 Jun; 27(3):236-246.. View in PubMed
  • Self-Directed Gambling Changes: Trajectory of Problem Gambling Severity in Absence of Treatment. J Gambl Stud. 2018 Dec; 34(4):1407-1421.. View in PubMed
  • Betting on Life: Associations Between Significant Life Events and Gambling Trajectories Among Gamblers with the Intent to Quit. J Gambl Stud. 2018 Dec; 34(4):1391-1406.. View in PubMed
  • Randomized trial of working memory training as an adjunct to inpatient substance use disorder treatment. Psychol Addict Behav. 2018 Dec; 32(8):861-872.. View in PubMed
  • Does Family History of Alcohol Use Disorder Relate to Differences in Regional Brain Volumes? A Descriptive Review with New Data. Alcohol Clin Exp Res. 2018 12; 42(12):2369-2384.. View in PubMed
  • A longitudinal investigation of the association between cannabis use and alcohol use among people living with HIV. Drug Alcohol Depend. 2018 12 01; 193:7-13.. View in PubMed
  • Correction to: Normative and Maladaptive Personality Trait Models of Mood, Psychotic, and Substance Use Disorders. J Psychopathol Behav Assess. 2018; 40(4):614.. View in PubMed
  • Stigma, Coping, and Alcohol Use Severity Among People Living With HIV: A Prospective Analysis of Bidirectional and Mediated Associations. Ann Behav Med. 2018 08 16; 52(9):762-772.. View in PubMed
  • Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention. Ann Behav Med. 2018 08 16; 52(9):787-797.. View in PubMed
  • Behavioural sensitization to alcohol: Bridging the gap between preclinical research and human models. Pharmacol Biochem Behav. 2018 10; 173:15-26.. View in PubMed
  • Does providing a brief internet intervention for hazardous alcohol use to people seeking online help for depression reduce both alcohol use and depression symptoms among participants with these co-occurring disorders? Study protocol for a randomised controlled trial. BMJ Open. 2018 07 19; 8(7):e022412.. View in PubMed
  • Normative and Maladaptive Personality Trait Models of Mood, Psychotic, and Substance Use Disorders. J Psychopathol Behav Assess. 2018; 40(4):606-613.. View in PubMed
  • Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers. Int J Neuropsychopharmacol. 2018 06 01; 21(6):503-512.. View in PubMed
  • Online interventions for problem gamblers with and without co-occurring problem drinking: study protocol of a randomized controlled trial. Trials. 2018 May 25; 19(1):295.. View in PubMed
  • Implicit Alcohol and Smoking Associations among Young Adult Heavy Drinkers: Associations with Smoking Status and Alcohol-Cigarette Co-Use. Motiv Emot. 2018 Oct; 42(5):682-690.. View in PubMed
  • A dual process perspective on advances in cognitive science and alcohol use disorder. Clin Psychol Rev. 2019 04; 69:83-96.. View in PubMed
  • Randomized Controlled Trial of a Brief Versus Extended Internet Intervention for Problem Drinkers. Int J Behav Med. 2017 10; 24(5):760-767.. View in PubMed
  • A Review of Developmental Considerations in Human Laboratory Alcohol Research. Curr Addict Rep. 2017 Dec; 4(4):364-378.. View in PubMed
  • Investigating the mediational role of negative urgency in the anxiety sensitivity pathway to cannabis problems and dependence symptoms among postsecondary students. J Am Coll Health. 2018 Feb-Mar; 66(2):69-75.. View in PubMed